A detailed history of Field & Main Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Field & Main Bank holds 12,606 shares of BMY stock, worth $722,701. This represents 0.23% of its overall portfolio holdings.

Number of Shares
12,606
Previous 13,656 7.69%
Holding current value
$722,701
Previous $567,000 14.99%
% of portfolio
0.23%
Previous 0.21%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$39.66 - $51.75 $41,643 - $54,337
-1,050 Reduced 7.69%
12,606 $652,000
Q2 2024

Jul 25, 2024

SELL
$40.25 - $52.99 $22,137 - $29,144
-550 Reduced 3.87%
13,656 $567,000
Q1 2024

Apr 29, 2024

SELL
$47.98 - $54.4 $22,838 - $25,894
-476 Reduced 3.24%
14,206 $770,000
Q4 2023

Feb 05, 2024

SELL
$48.48 - $57.85 $50,661 - $60,453
-1,045 Reduced 6.64%
14,682 $753,000
Q3 2023

Oct 12, 2023

BUY
$57.89 - $64.73 $233,007 - $260,538
4,025 Added 34.4%
15,727 $912,000
Q2 2023

Jul 26, 2023

SELL
$63.71 - $70.74 $3,185 - $3,536
-50 Reduced 0.43%
11,702 $748,000
Q1 2023

Apr 19, 2023

SELL
$65.71 - $74.53 $9,199 - $10,434
-140 Reduced 1.18%
11,752 $814,000
Q4 2022

Jan 19, 2023

SELL
$68.48 - $81.09 $3,424 - $4,054
-50 Reduced 0.42%
11,892 $0
Q3 2022

Oct 25, 2022

SELL
$0.13 - $76.84 $28 - $16,981
-221 Reduced 1.82%
11,942 $849,000
Q2 2022

Jul 18, 2022

BUY
$72.62 - $79.98 $181,259 - $199,630
2,496 Added 25.82%
12,163 $937,000
Q1 2022

Apr 21, 2022

SELL
$61.48 - $73.72 $9,529 - $11,426
-155 Reduced 1.58%
9,667 $706,000
Q4 2021

Feb 01, 2022

SELL
$53.63 - $62.52 $61,674 - $71,898
-1,150 Reduced 10.48%
9,822 $612,000
Q3 2021

Oct 14, 2021

SELL
$59.17 - $69.31 $7,100 - $8,317
-120 Reduced 1.08%
10,972 $649,000
Q2 2021

Jul 15, 2021

SELL
$61.91 - $67.42 $3,033 - $3,303
-49 Reduced 0.44%
11,092 $741,000
Q1 2021

Apr 30, 2021

BUY
$59.34 - $66.74 $5,934 - $6,673
100 Added 0.91%
11,141 $703,000
Q4 2020

Feb 25, 2021

SELL
$57.74 - $65.43 $61,204 - $69,355
-1,060 Reduced 8.76%
11,041 $685,000
Q3 2020

Oct 22, 2020

BUY
$57.43 - $63.64 $19,813 - $21,955
345 Added 2.93%
12,101 $730,000
Q2 2020

Aug 12, 2020

BUY
$54.82 - $64.09 $66,058 - $77,228
1,205 Added 11.42%
11,756 $691,000
Q4 2019

Feb 03, 2020

BUY
$49.21 - $64.19 $71,108 - $92,754
1,445 Added 15.87%
10,551 $677,000
Q3 2019

Nov 07, 2019

SELL
$42.77 - $50.71 $52,564 - $62,322
-1,229 Reduced 11.89%
9,106 $462,000
Q2 2019

Jul 22, 2019

SELL
$44.62 - $49.34 $52,428 - $57,974
-1,175 Reduced 10.21%
10,335 $469,000
Q1 2019

Apr 24, 2019

SELL
$45.12 - $53.8 $158,145 - $188,569
-3,505 Reduced 23.34%
11,510 $549,000
Q3 2018

Oct 23, 2018

SELL
$55.19 - $62.25 $8,278 - $9,337
-150 Reduced 0.99%
15,015 $932,000
Q2 2018

Aug 13, 2018

BUY
$50.53 - $62.98 $49,519 - $61,720
980 Added 6.91%
15,165 $891,000
Q1 2018

May 01, 2018

SELL
$59.92 - $68.98 $17,976 - $20,694
-300 Reduced 2.07%
14,185 $0
Q4 2017

Jan 24, 2018

BUY
$59.94 - $65.35 $868,230 - $946,594
14,485
14,485 $887,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Field & Main Bank Portfolio

Follow Field & Main Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Field & Main Bank, based on Form 13F filings with the SEC.

News

Stay updated on Field & Main Bank with notifications on news.